Clinical Trial Update: An Open-Label Trial of Donepezil in Fragile X Syndrome [Phase 1]

View source ↗

Summary

Open-label Phase 1 trial evaluating donepezil for Fragile X Syndrome has completed at Stanford University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Stanford University | Conditions: Fragile X Syndrome | Phase 1 | Status: COMPLETED